The addition of acute-phase apolipoprotein serum amyloid A (SAA) to cultured aortic smooth-muscle cells caused a decrease in the incorporation of ["%C]acetate into lipids. Optimal inhibition of lipid biosynthesis was achieved with 2 µM SAA, and the effect was maintained for up to 1 week when SAA was included in the culture medium. Lipid extracts were subjected to TLC and it was determined that the SAA-induced decrease in ["%C]acetate incorporation into lipids was attributable to decreases in cholesterol, phospholipid and triglyceride levels. The accumulated mass of cholesterol and phospholipid in SAA-treated cultures was significantly less than that of controls, with no change in the accumulated protein. Moreover, SAA had no effect on either
INTRODUCTION
The serum amyloid A (SAA) proteins are a family of apolipoproteins that are up-regulated by inflammatory cytokines, including interleukin (IL)-1 and IL-6, which are major regulators of biochemical changes in the body when homeostasis has been disrupted [1, 2] . The family of six known human isoforms is encoded by three genes (SAA "
, SAA # and SAA % ). During inflammation there are marked changes in the concentration of the acute-phase isoforms SAA " and SAA # , but not of the constitutively expressed isoform, SAA % [3] . In addition, SAA $ , expressed in rabbit, hamster and mouse, is an acute-phase isoform but appears to be a pseudogene in human. The acutephase isoforms are synthesized by the liver, in which maximal levels of SAA are achieved by a combination of IL-1 and IL-6 [4] [5] [6] . The extrahepatic synthesis of SAA $ by synovial fibroblasts, macrophages and adipocytes [7] [8] [9] has also been documented. More recently, work in our laboratory demonstrated that, in response to IL-1α alone, cultured aortic smooth muscle cells synthesize and secrete acute-phase SAA [10] .
An acute-phase response including elevated plasma SAA levels in connection with myocardial infarction has been documented [11] [12] [13] [14] [15] [16] [17] [18] [19] . Evidence suggests that SAA is associated with the atherosclerotic plaque in mice [20] [21] [22] [23] [24] and humans [8, 25, 26] . Moreover, it has been shown that SAA accumulates in the brains of those afflicted with Alzheimer's disease, a condition in which chronic inflammation in the brain is thought to occur [27] . Although the regulation of the synthesis of SAA in response to inflammatory mediators has been the subject of many investigations, the function of this family of proteins remains speculative. It has been suggested that the association of SAA with high-density lipoprotein (HDL) might alter the metabolism of Abbreviations used : DMEM, supplemented Dulbecco's modified Eagle's medium ; FBS, fetal bovine serum ; HDL, high-density lipoprotein ; IL, interleukin ; LDL, low-density lipoprotein ; LDS, lipoprotein-deficient serum ; SAA, apolipoprotein serum amyloid A ; SAA p , recombinant human SAA ; TCA, trichloroacetic acid. 1 To whom correspondence should be addressed (e-mail schreibe!biochem.bumc.bu.edu). 2 Present address : National Institutes of Health, SSS2, CSR, 6701 Rockledge Drive, Bethesda, MD 20814-9692, U.S.A.
protein synthesis or DNA synthesis, suggesting that SAA specifically alters lipid synthesis. By using a peptide corresponding to the cholesterol-binding domain of acute-phase SAA (amino acids [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , it was shown that this region of the molecule was as effective as the full-length protein in decreasing lipid synthesis and the accumulation of cholesterol and phospholipid. The implications of these findings for atherosclerosis and Alzheimer's disease are discussed.
the lipoprotein particle, thereby compromising its protective effect against atherosclerosis [28] [29] [30] [31] [32] . SAA was shown to decrease lecithin :cholesterol acyltransferase activity [32] and to enhance the activity of phospholipase A # [33] . Moreover, SAA might contribute to the decreased half-life of apolipoprotein A-I [34] . Mitchell et al. [7] reported that SAA is produced by rabbit synovial fibroblasts as an autocrine factor that stimulates collagenase and stromelysin. A variety of additional effects have been noted, including the inhibition of the oxidative burst by neutrophils [35] and others as reviewed by Husby et al. [3] . Our group has shown a potential role for SAA in intracellular lipid metabolism by studies in which acute-phase SAA bound and enhanced the uptake of cholesterol by HepG2 cells [36] and rabbit neonatal aortic smooth muscle cells [37] .
Here we show that SAA down-regulates lipid biosynthesis in smooth muscle cells. Moreover, a synthetic peptide corresponding to the cholesterol-binding region of acute-phase SAA is as effective as the full-length molecule in decreasing the ability of the cells to synthesize lipids.
EXPERIMENTAL Reagents
Recombinant SAA (SAA p ), purchased from PeproTech (Rocky Hill, NJ, U.S.A.), corresponds to acute-phase human SAA, as described previously [37] . Freeze-dried SAA p was dissolved in water at 1 mg\ml and stored at k20 mC. The purity was confirmed by electrospray ionization MS (Boston University School of Medicine Mass Spectrometry Resource, Boston, MA, U.S.A.). Synthetic peptides corresponding to residues 1-18 of human SAA "
(SAA " 1-18), the reverse peptide corresponding to residues 18-1 of human SAA " (SAA " 18-1) and residues 1-18 of human SAA % (SAA % 1-18) were synthesized and purified as described previously [37] . Freeze-dried peptides were dissolved in DMSO at 10 mg\ml and stored at k20 mC until use. A stock solution of cholesterol (10 mg\ml) was prepared in ethanol.
Isolation and culture of neonatal rabbit aortic smooth muscle cells
Neonatal rabbit aortic smooth muscle cells were isolated aseptically from the aortae of 3-day-old New Zealand White rabbits (Pine Acres Rabbitry, Brattleboro, VT, U.S.A.) as described previously [38] . The primary cultures were maintained in Dulbecco's modified Eagle's medium (DMEM) (cat. no. 56-469-111 ; J. R. H. Biosciences, Lenexa, KS, U.S.A.) supplemented with 3.7 g\l NaHCO $ , 100 i.u.\ml penicillin, 100 µg\ml streptomycin, 0.1 mM MEM non-essential amino acids (Gibco Laboratories, Grand Island, NY, U.S.A.), 1 mM MEM sodium pyruvate solution (Gibco Laboratories) and 20 % (v\v) fetal bovine serum (FBS ; Sigma Chemical Co) for 1 week, after which they were treated with 0.5 % trypsin\0.02 % EDTA (Gibco Laboratories) and plated in DMEM containing 10 % (v\v) FBS at a density of 2.0i10%\cm#. Studies were performed with cells in their second or third passage. Spent medium was replaced twice weekly.
Treatment of cells with free and SAA p -bound cholesterol
Cholesterol bound to SAA p was prepared by diluting free cholesterol and\or SAA p in medium containing 10 % (v\v) lipoprotein-deficient serum (LDS ; prepared as described previously [39] ) at 37 mC for 2 h (vehicle controls included the appropriate volumes of ethanol and\or water). Before the addition of the reagents, the media were removed and the cells were washed twice with Puck's saline [140 mM NaCl\5.4 mM KCl\1.1 mM KH # PO % \1.1 mM Na # HPO % \6.1 mM glucose (pH 7.4)]. The media containing the reagents were then added and incubated for 7 days. The media and reagents were replaced twice weekly. The cell cultures were radiolabelled with ["%C]acetate to determine the levels of lipid biosynthesis as described below.
Treatment of cells with SAA p and synthetic peptides
Before the addition of reagents to the cells, the media were removed and the cells were washed twice with Puck's saline. Media containing 10 % (v\v) LDS were added to the cells and then SAA p , synthetic peptides, BSA or vehicle control (water or DMSO) was added. In cultures treated for more than 3 days, the media were aspirated and the cells re-fed with fresh media plus reagents twice weekly, including the day before harvest in each case. After the indicated incubation, the biosynthesis of lipids, the accumulation of cholesterol, phospholipid or protein, the synthesis of proteins and the synthesis of DNA were measured as described below. 
Incorporation of

Measurement of total cholesterol accumulation
Total cholesterol levels were determined in cells plated on multiwell tissue-culture trays (3.8 cm# per well). The cells were treated with reagents including SAA p , synthetic peptides, BSA or vehicle control, as described above, for the indicated durations.
On the day of harvest, the cells were washed and extracted with hexane\propan-2-ol, as described above. Total cholesterol levels were measured with a fluorometric technique as previously described [39] . The hexane\propan-2-ol in the lipid extracts was removed by evaporation under a stream of N # . The lipids were resolubilized in propan-2-ol ; total cholesterol was determined by comparison with standard curves run with each assay. In addition, cell layer protein was solubilized with 0.2 M NaOH and quantified by the procedure of Lowry et al. [40] , with BSA as a standard. Results are expressed as µg of cholesterol\mg of protein (meanspS.D.).
Measurement of total phospholipid accumulation
Total phospholipid levels were determined in cells plated into multi-well tissue-culture trays (3.8 cm# per well). The cells were treated with reagents including SAA p , synthetic peptides, BSA or vehicle control as described above, for the indicated duration. On the day of harvest, the cells were washed and extracted with hexane\propan-2-ol as described above. An aliquot to be analysed was dried under a stream of N # and water\chloroform\ methanol (1 : 2 : 1, by vol.) was added. After vortex-mixing, samples were incubated on ice for 15 min, after which they were subjected to centrifugation on a Microfuge for 10 min on high speed. The organic phase was transferred to Pyrex test tubes and the solution was dried under a stream of nitrogen. Total phospholipid levels were determined by measuring phosphorus with the technique of Svanborg and Svennerholm [41] . Essentially, total phosphorus was determined by comparison with standard curves by using KH # PO % run with each assay. To each sample was added 0.5 ml of 4.5 % HClO % \27 % H # SO % and tubes were heated at 180 mC for 3 h. After cooling to room temperature, 5 ml of the colour reagent (a 10 : 1 dilution of solutions containing 2.5 mg\ml ammonium molybdate, 8.2 mg\ml sodium acetate and 100 mg\ml ascorbic acid respectively) was added and the tubes were incubated for 2 h at 37 mC. The absorbance was measured spectrophotometrically at 820 nm. The mass of phospholipid was estimated by multiplying the phosphorus content by 25, as described by Svanborg and Svennerholm [41] . In addition, cell layer protein was solubilized with 0.2 M NaOH and quantified by the procedure of Lowry et al. [40] , with BSA as a standard. Results are expressed as µg of phospholipid\mg of protein (meanspS.D.). Serum amyloid A decreases smooth-muscle cell lipid synthesis
Measurement of protein synthesis
Protein synthesis was determined in cells plated into multi-well tissue-culture trays (3.8 cm# per well). The cells were treated with reagents including SAA p , BSA or vehicle control as described above, for the indicated duration. At 4 h before harvest, -[3,4,5-$H]leucine (180 Ci\mmol ; NET-460, Dupont NEN Research Products), 25 µCi\ml of media, was added. At the time of harvest, media were removed and PMSF and p-chloromercuribenzoate were added to final concentrations of 50 and 300 µM respectively. The cell layers were washed three times with Puck's saline, water was added (0.5 ml per well) and the cells were scraped with a Teflon cell scraper. The cells were transferred to a tube and the wells were rewashed with a further 0.5 ml of water. The cell layers were then homogenized with a glass\glass homogenizer, followed by freeze-drying.
Trichloroacetic acid (TCA) was added to an aliquot of radiolabelled medium (0.5 ml) to achieve a final concentration of 10 % (w\v) ; the reaction mixture was incubated on ice for 15 min, after which it was subjected to centrifugation in a Microfuge for 10 min on high speed. The supernatant was discarded and the pellet was washed twice with 10 % (w\v) TCA diluted in PBS. The final pellet was dissolved in 0.5 ml of 0.1 M NaOH and the TCA-insoluble radioactivity was determined by liquid-scintillation spectrometry. The cell layers were reconstituted in 0.5 ml of PBS containing 3 mg\ml BSA ; TCA was added to achieve a final concentration of 10 % (w\v). The cell layers were then processed as described above for the culture medium. Results are expressed as c.p.m. in [$H]leucine in each well (meanspS.D.). Research Products), 20 µCi\ml of medium, was added and the cells were radiolabelled for 4 h. Cells were harvested and the incorporation of [$H]thymidine into DNA was assessed as described previously [38] . 
Analysis of incorporation of [ 3 H]thymidine into DNA
Statistical analysis
Experimental groups were compared by one and two-factor analysis of variance. Statistically significant differences of relevant comparisons are reported when P 0.05 by post-hoc analysis with Fisher protected least-squares difference.
RESULTS
SAA decreases lipid biosynthesis in smooth muscle cells
Our observations that acute-phase SAA binds and transports cholesterol into aortic smooth muscle and HepG2 cells [36, 37] suggest that SAA might have a role in cholesterol homoeostasis during chronic inflammation in diseases including atherosclerosis Figure 1 show that the total radioactivity incorporated into lipids decreased in the presence of SAA p whether or not it had been added in the presence of cholesterol, i.e. SAA p alone was capable of down-regulating lipid synthesis. In a study designed to determine the optimal dose of SAA p , and the time course of SAA p -induced down-regulation of lipid biosynthesis, smooth muscle cells were incubated with 1, 2 or 4 µM SAA p or under control conditions for up to 7 days. On the day of harvest, the cells were radiolabelled with ["%C]acetate, the cell layers were harvested and lipid biosynthesis was measured by evaluating the amount of radioactivity incorporated into lipid. The data in Figure 2 (A) show that treatment with 2 µM SAA p resulted in a significant decrease in ["%C]acetate incorporation. Lipid synthesis in SAA p -treated cultures was 39 % and 49 % of that in control cultures on days 4 and 7 respectively. The effect of the higher dose (4 µM SAA p ) was approximately equivalent to that of 2 µM SAA p . Figure 2(B) shows that, despite the decrease in lipid synthesis, the total protein remaining in the cultures treated with SAA p was equal to that in the control cultures, and that the expected accumulation of protein by the cultured cells during the duration of the experiment was not inhibited by SAA p .
Synthesis of cholesterol as well as that of triglycerides and phospholipids is affected by SAA
To ascertain the contribution of various lipid classes to the SAA p -induced effect, extracts of cells incubated in the presence or absence of SAA p were subjected to TLC. Interestingly, the results in Table 1 show that the down-regulation of ["%C]acetate incorporation into lipids was attributable to a decrease in triglyceride and phospholipid synthesis in addition to decreased synthesis of cholesterol.
Figure 3 SAA decreases accumulation of cholesterol and phospholipid
Neonatal rabbit aortic smooth muscle cells were incubated in the presence or absence (control) of SAA p [SAA ; 2 µM (24 µg/ml)] for 6 days, after which both lipids and proteins were extracted as described in the Experimental section ; the amount of total cholesterol was determined and is expressed as µg/mg of protein (meanspS.D. ; hatched columns) and the amount of total phospholipid was determined and is expressed as meani10 − 1 i(µg/mg of protein) (meanspS.D. ; grey columns). A statistical analysis of the data demonstrated that both total cholesterol and total phospholipid accumulation in control cultures were significantly different from those in SAA p -treated cultures.
Figure 4 SAA has no effect on protein synthesis
Neonatal rabbit aortic smooth muscle cells were incubated in the presence or absence (control) of SAA p [SAA ; 2 µM (24 µg/ml)] or BSA (24 µg/ml) for 8 days, after which the cell cultures were radiolabelled with To determine whether the SAA p -induced decrease in lipid biosynthesis resulted in a decrease in cellular lipid mass, the cells were exposed to SAA p for 6 days. In considering the results of these experiments, it is important to note that the confluent cultures accumulate a substantial amount of cellular cholesterol and phospholipid, so comparisons are always against the relatively large mass of lipid in control cultures. The data in Figure  3 demonstrate that despite this, the total in SAA p -treated cultures was significantly lower than that in control cultures. The same cultures were also evaluated for total phospholipid : SAA ptreated cells had significantly less phospholipid than the control cultures. Serum amyloid A decreases smooth-muscle cell lipid synthesis 
SAA has no effect on synthesis of protein or DNA
To establish that acute-phase SAA specifically altered lipid biosynthesis, protein synthesis and DNA synthesis were measured after incubation with the reagents. The effect of SAA p on protein synthesis was ascertained by evaluating the incorporation of [$H]leucine into TCA-precipitable radioactivity in the media and cell-layer fractions of cultures that had been incubated with the reagents for 8 days and then radiolabelled with [$H]leucine for 4 h before harvest. When compared with control (vehicle-treated) or BSA-treated cultures, the data in Figure 4 show that protein synthesis remained unchanged in cells that had been treated with SAA p .
To assess the effect of SAA p on the rate of cell proliferation, the cells incubated in its presence were radiolabelled with [$H]thymidine and its incorporation into DNA was analysed as described in the Experimental section. The data in Figure 5 demonstrate that exposure to SAA p for either 4 or 8 days had no effect on this parameter in that [$H]thymidine incorporation into DNA was unchanged in comparison with control or BSAtreated cultures.
The cholesterol-binding region of acute-phase SAA is responsible for the decrease in lipid biosynthesis
In previous studies we reported that SAA p binds and enhances cholesterol uptake into HepG2 and aortic smooth muscle cells via the N-terminal region corresponding to the first 18 amino acid residues of the protein [36, 37] . The ability to bind cholesterol was unique to the acute-phase isoforms of SAA (SAA " and SAA # ) ; in other words, the consitutive isoform (SAA % ) did not display the ability to transport cholesterol into cells. To determine whether the lipid-lowering effect of SAA p was dependent on its ability to bind cholesterol, the effect of a synthetic peptide corresponding to residues 1-18 of acute-phase SAA was evaluated for its effect on lipid biosynthesis. Two additional peptides were tested, including one in which residues 1-18 of acute-phase SAA were placed in the reverse order (i.e. 18-1) and a peptide corresponding to residues 1-18 of SAA % . The peptides were introduced in DMSO (as opposed to H # O for the full-length SAA p ), so an additional vehicle control was therefore included. Neonatal aortic smooth muscle cells were incubated with the reagents for 8 days, after which the cultures were radiolabelled for 4 h with ["%C]acetate and its incorporation into total lipids was measured. The data in Figure 6 (upper panel) confirm that the radioactivity in ["%C]acetate incorporated\mg of protein in cultures incubated with full-length SAA p was significantly less than in cultures incubated with either vehicle alone or BSA. The data also show that when peptides corresponding to residues 1-18 of acute-phase SAA (SAA " 1-18) were used, lipid biosynthesis was similarly down-regulated ; however, neither the reverse peptide (SAA " 18-1) nor the peptide corresponding to residues 1-18 of constitutive SAA (SAA % 1-18) was active. Once again, comparisons of the mass of total protein in all treatment groups showed no statistically significant differences ( Figure 6 , lower panel).
Both total cholesterol and total phospholipid were also analysed ; the data in Figure 7 show that the decrease in lipid 
DISCUSSION
The data reported here demonstrate that SAA inhibits lipid synthesis in aortic smooth muscle cells and that these metabolic changes might be of consequence during the acute-phase response and\or situations in which chronic inflammation persists. During an acute-phase response, plasma levels of SAA rise markedly and can reach more than 1000 µg\ml. The levels attained in the atherosclerotic plaque have not been determined but localized concentrations in chronically affected areas are likely to be substantially lower than those achieved during an acute-phase response. The demonstration that as little as 2 µM SAA (24 µg\ml) effectively down-regulates lipid synthesis suggests that this effect is potentially physiologically relevant.
The alteration in lipid biosynthesis results in a significant decrease in the mass of both cholesterol and phospholipid in the cell cultures. Frank toxicity was not evident from measurements of DNA synthesis as well as protein synthesis and accumulated total protein. As previous work demonstrated that the proliferative rate of the cells diminishes as the cultures become confluent and form multilayers [39] , the rate of DNA synthesis was low in the confluent cultures examined in these studies. It would be of interest to determine whether factors related to the proliferation and\or differentiation of smooth muscle cells have any effect on the SAA-induced decrease in lipid biosynthesis. Such studies could shed additional light on the potential for SAA-induced changes in atherosclerosis, a disease associated with the migration of smooth muscle cells from the medial layer of the blood vessel to its intima, a process accompanied by phenotypic changes in the cell [43] [44] [45] [46] [47] . Several reports have suggested that SAA is associated with the atherosclerotic plaque [9, [20] [21] [22] [23] [24] [25] [26] . It has been speculated that SAA might appear at the site of lesion development in atherosclerosis via plasma-derived HDL or LDL [25, 26] . Although SAA is most often found associated with HDL in plasma, there is evidence to suggest that it can be dissociated from HDL in tissues [48] . Several important functional studies of SAA have addressed the role of non-lipidbound SAA on the chemotaxis of monocytes, neutrophils and T-lymphocytes [49] [50] [51] [52] ; these authors discuss the possibility that local increases in SAA at the site of inflammation could form a gradient of the free protein. Our previously reported results demonstrating that IL-1α induces SAA $ synthesis and secretion by cultured aortic smooth muscle cells [10] suggest (1) that an inflammatory response to injury in the vasculature can lead to the local synthesis of SAA, which might be at least partly responsible for its accumulation at the site of lesion development, and (2) that as a result of local synthesis, SAA is potentially available in the smooth muscle cell microenvironment in a free, non-lipoprotein-bound form. It is also worthy of note that cultured neonatal aortic smooth muscle cells have been shown to assemble an apolipoprotein-E-containing HDL particle in the culture medium [53] . It is therefore likely that at least some of the exogenously added SAA was associated with lipoproteins in the medium and was therefore lipid-bound during the time course of the experiments described here. Comparisons of lipid biosynthesis in the presence of free SAA and of SAA bound to HDL will address the question of whether conformational changes might alter the ability of SAA to down-regulate lipid biosynthesis in smooth muscle cells and whether circulating and\or locally available SAA in the vessel wall can modify lipid homoeostasis.
Of particular interest is consideration of the finding that the peptide corresponding to residues 1-18 of the acute-phase isoforms of SAA was capable of down-regulating lipid biosynthesis as effectively as the full-length protein. Previous comparisons showed that differences in amino acid composition between SAA " and SAA % in this region account for the ability of the acute-phase isoform to bind cholesterol, whereas the constitutive isoform cannot [37] . As it is this portion of SAA that is responsible for binding and enhancing the uptake of cholesterol into smooth muscle cells [36, 37] , these results show clearly that the ability to bind cholesterol is critical to the processes involved in regulating lipid synthesis. Because the addition of exogenous cholesterol is not a requirement for the SAA-induced decrease in lipid biosynthesis (see Figure 1) , the process must be dependent on the trafficking of endogenously synthesized cholesterol. Cholesterol homeostasis in cells is critical in that excess accumulation can cause cell death and deposition in arteries leading to atherosclerosis ; however, many cellular functions are dependent on it. Studies of the regulation of lipid metabolism in other cell systems led to the identification of a novel family of transcription factors known as the sterol-response-element-binding proteins (SREBPs) whose function is dependent on the cholesterol status of cells [54] . Target genes containing sterol response elements (SREs) to which SREBPs bind and activate transcription include those associated with cholesterol biosynthesis, cholesterol uptake via lipoproteins, and fatty acid synthesis [54] [55] [56] . The ability of SAA to contribute to changes in SREBP-mediated smooth muscle cell gene transcription via alterations in its ability to transport cholesterol into the cells is the subject of current investigation.
Finally, recent novel findings have shown that patients afflicted with Alzheimer's disease accumulate acute-phase SAA isoforms in the brain [27] . The decrease in lipid synthesis by SAA suggests a link between the documentation of an inflammatory response associated with the illness and the demonstration that the brains of patients with Alzheimer's disease have decreased levels of cholesterol and phospholipid [57, 58] .
In summary, the results in this paper demonstrate that acutephase SAA down-regulates lipid biosynthesis in cultured aortic smooth muscle cells in a time-and dose-dependent manner. Moreover, the mass of both cholesterol and phospholipid decreases in SAA-treated cells. Finally, it appears that the ability of SAA to bind and transport cholesterol is critical to its capability of inducing changes in lipid homoeostasis.
